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1. Introduction 
The pathogenesis of serum-resistance Salmonella infections seems to be connected with a 
variety of their surface structures. Salmonella resistance to innate immune factors aids the 
despersal of bacteria in host tissues and body fluids. This paper shows the natural resistance 
of clinical S. Enteritidis, S. Typhimurium, and S. Hadar strains to the antibacterial activity of 
human serum. Curiously, some of the pathogens modify their lipopolysaccharide (LPS) to 
escape host surveillance. A well-known strategy developed by bacteria is sialylation with 
sialic acid (NeuAc) of surface structures to mimic host tissues. It is very interesting, that 
even though LPS of the same chemical structure covers Salmonella O48, these bacteria differ 
in their susceptibility to the antibacterial activity of serum. Previous results indicate that the 
presence of sialylated LPS do not protect Salmonella O48 against the bactericidal activity of 
human and animal serum, and the presence of NeuAc in the LPS structure is not sufficient 
to block activation of the alternative pathway of complement in serum. Because outer 
membrane proteins (OMPs) are also surface virulence factors and have a significant role in 
pathobiology and bacterial adaptation to environmental conditions, researchers have 
directed their investigations through the analysis of Salmonella OMPs patterns and have 
attempted to identify among them key molecular targets of the protective immune response 
against Salmonella. This work also highlights the importance of OMPs as candidates for 
vaccine targets. In this review, we have collected and discussed published results, as well as 
new ones, shown for the first time. 
2. Salmonellosis – An emerging problem 
Salmonella enterica is a main ethological factor for infectious diseases worldwide (Hohmann, 
2001; Rabsch et al., 2001). Serotypes, which cause disease, are divided into the following 
groups: typhoid species (TS) that are human specific pathogens (Typhi and Paratyphi 
serotypes) and non-typhoid species (NTS) spread to humans from animal sources. The most 
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common non-typhoid Salmonella spp. serovars have a potential to cause two basic kinds of 
infections: gastroenteritis and extraintestinal infections. The host environment varies from 
the ubiquitous (non-host-adapted) serovars for example Typhimurium and Enteritidis, to 
host restricted - S. Dublin, S. Choleraesuis. Both can cause infection in cattle, pigs or 
humans, and host-specific ones – e.g. S. Pullorum, which is found in chickens only. About 
5% of patients with gastrointestinal illness of non-typhoid Salmonella spp. serotypes develop 
bacteremia (Hohmann, 2001). The survival of S. Enteritidis in poultry products has been 
linked to its remarkable ability to quick respond to environmental signals and adapt to its 
surroundings. S. Enteritidis may exist naturally in poultry at low incidence but it seems to 
have another reservoir, rodents. Human cases of S. Enteritidis rapidly increased through the 
1980s and 1990s. For the last few decades, S. Hadar has been one of the main common 
serotypes isolated from foodborne disease in Europe. In humans, S. Hadar usually causes 
gastroenteritis, characterized by non-bloody-diarrhea, vomiting, nausea and fever (Rowe et 
al., 1980). Non-typhoid Salmonella spp. (NTS) are broadly dispersed in the environment as 
well as in the gastrointestinal tracts of both domesticated and wild animals. Up to 90% of 
Salmonella infections in the United States are food-borne in origin (CDC, 2009). Regardless of 
the fact that non-typhoid Salmonella spp. gastroenteritis is most often self-limited, these 
bacteria cause the most food-borne disease worldwide. Among the conditions for 
salmonellosis to develop are: gastric hypoacidity, extremes of age, alteration of the 
endogenous flora, diabetes, rheumatological disorders, sickle cell disease, malaria and 
immunosuppression (Bronzan et al., 2007). 
In developed countries, the main risk factor for acquisition of typhoid Salmonella 
bacteraemia is travel to an endemic region, however, non-typhoid Salmonella may more 
often lead to food-borne diseases in non-endemic countries (Simonsen et al., 2010; Scallan et 
al., 2011). Invasive NTS is endemic in sub-Saharan Africa where it is a leading cause of fatal 
bacteremia among African children and HIV-infected adults. Increasing levels of antibiotic 
resistance among African strains of NTS indicate that a vaccine is urgently needed (Siggins 
et al., 2011). In Malawi, MacLennan et al. (2008) recently found that NTS bacteriemia 
particularly affects African children between 4 months and 2 years of age, the period in 
which immunoglobulin levels to NTS are low or absent. Mortality for nontyphoid Salmonella 
is reported to be as high as 60% in African patients with HIV (Boyle et al., 2007).  
The local inflammation of specific tissues or organs also called focal infections can cause 
diseases such as: pneumonia, meningitis, endocarditis, or infections of the urinary tract 
(Ekman et al., 2000; Tena et al., 2007; Kedzierska et al., 2008). Gastroinestinal infection due to 
Salmonella may also lead to reactive arthritis (ReA) (Yu, 1999). It has been suggested that the 
persistence of bacterial antigens is typical of ReA, and is a result of the ineffective 
elimination of microbes in patients with post infection complications (Granfors et al., 1998). 
Data presented by Locht et al. (1993) and Thomson et al. (1995) indicated that 1–15% of 
individuals infected with Salmonella gastroenteritis develop a postinfection ReA. Despite the 
fact that most Salmonella strains are pathogenic to humans and animals, their virulence 
seems to be different depending on the serovar (Threlfall, 2005). Serovars of Salmonella 
belonging to somatic antigen group O48 are clinically important bacteria causing intestinal 
dysfunction and diarrhoea in animals, infants and children. Table 1 includes epidemiologic 
data (1984-2008) of the distribution of S. enterica and S. bongori strains in animals world-
wide. Note that reptiles are the hosts for the greatest number of Salmonella serovars 
producing diseases especially in children. 
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Table 1. The distribution of Salmonella isolates in animals, selected cases in period 1984-2008 
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In Poland, a total of 13,362 salmonellosis cases were reported in 2006, and 11,934 in 2007. In 
2007 the incidence rate was 30.7 per 100.000 population. The most common type of 
outbreaks (251 recorded cases) was household outbreaks. Over seventy percent of patients 
were hospitalized. As in previous years, the seasonal peak of outbreak in Poland was 
observed in July and August. S. Enteritidis was the most frequently isolated serotype of 
Salmonella and constituted over 80% of cases. Two-year old children were the most affected 
age group (Lazinska et al., 2005; Sarowska et al., 2005). The relative high burden of S. 
Enteritidis in Europe accounts for 67% of salmonellosis, and of S. Typhimurium accounts for 
9% of the cases (de Jong and Ekdahl, 2006). However, the proportion of S. Enteritidis cases 
from different countries varied from 25% (Iceland) to 98% (Latvia). S. Enteritidis is currently 
the second most frequently isolated serovar in the United States - accounting for nearly 15% 
of reported human salmonellosis cases (Callaway et al. 2008).  
3. Susceptibility of Salmonella spp. to the bactericidal activity of serum 
It is known that complement and bactericidal activity of serum may protect healthy hosts 
from invasion of serum sensitive microorganisms (Gondwe et al., 2010). Complement (C) 
is a part of the innate adaptive immune system and it consists of at least 35 proteins, 
mainly in pre-activated enzymatic forms. Bacterial invasion activates this defense host 
system in a few seconds. The complement system mainly recognizes and promotes the 
clearance of invading microorganisms and host cells damaged by phagocytosis. The 
following three mechanisms lead to complement activation: the classical pathway (CP), 
the alternative pathway (AP), and the lectin pathway (LP), which results in membrane 
attack complex (MAC, C5b-9) formation. It has been suggested that complement is 
necessary for protection against microbial infection. Immunoglobulins (Ab) can 
potentially protect against salmonellosis. Ab can protect in a cell-independent manner 
through complement-dependent bactericidal activity and by opsonizing bacteria for 
uptake and killing by phagocytic cells (Würzner, 1999; Morgan, 1999). 
Resistance to complement-mediated killing is a key virulence property of microbial 
pathogens, such as Salmonella strains. Long-chain LPS has been shown to confer resistance 
by promoting the deposition of C components at a distance from the outer membrane (OM), 
thus preventing membrane disruption with MAC (Bravo et al., 2008). The surface-exposed 
protein, PagC has been shown to confer resistance when present in S. Choleraesuis (Nishio 
et al., 2005). The surface protease PgtE also mediates serum resistance presumably via 
its ability to cleave C components C3, C4, and C5 (Ramu et al., 2007). TraT, an OMP has 
been found to inhibit complement at the MAC formation stage (Pramoonjago et al., 1992). 
Rck is a 17-kDa protein structurally related to PagC and has been shown to inhibit MAC 
function. Rck belongs to a family of 17-19 kDa OMP including PagC, OmpX and Ail. 
Nevertheless, these proteins have been shown to confer resistance in Gram-negative bacteria 
to C-mediated killing. Ho and co-workers (2010) presented evidence that Rck of S. 
Typhimurium and S. Enteritidis expressed in E. coli BL21 with a defective galE gene binds 
the regulator of the AP factor H. fH binding is accociated with resistance to the AP and 
reduced deposition of C3b, Bb and MAC. Biedzka-Sarek and co-workers (2008) observed 
that Ail was not masked by distal region of LPS, such as O-antigen. Further investigations 
are required to determine if LPS length plays a role in fH binding to Rck. LPS with a sialic 
acid moiety within an O-specific chain also regulates AP amplification by binding fH, hence 
preventing activation of the C system through the alternative pathway. 
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Sialic acids present in the surface antigens of bacteria may contribute to the pathogenicity 
of the microorganisms by mimicking host tissue components (Vimr and Lichtensteiger, 
2002). Serovars Enteritidis, Typhimurium, and Hadar do not possess sialylated O-
antigens. Results presented by Cisowska et al. (2004) indicate that encapsulated E. coli K1 
strains have different degrees of susceptibility to the bactericidal action of normal human 
serum (NHS). These results confirm previous observations (Mielnik et al., 2001) 
concerning sialylated LPS of Salmonella spp., Escherichia spp., Citrobacter spp., and Hafnia 
spp. Lipooligosaccharide sialylation in Neisseria meningitidis serogroup C is a critical 
determinant of MBL binding. Data provided by Jack et al. (2001) idicate that sialylation 
down-regulates the rate of MBL-mediated C activation. In nonsialylated microorganisms, 
MBL increased the rate of acquisition of C5b-9.  
Long-term investigations carried out on Salmonella O48 shown that strains differ in the 
susceptibility to various sera, human or animal (Bugla-Ploskonska et al., 2011, 2010a, 2010b, 
2009b, 2009c; Futoma et al. 2005). These authors suggest that the presense of sialylated 
LPSs do not play a decisive role in determining bacterial resistance to the bactericidal 
activity of serum, and that the presence of NeuAc in the LPS structure is not sufficient to 
block activation of the alternative pathway of complement in serum. Curiously, even 
though LPS of the same chemical structure cover Salmonella O48, they differ in the 
susceptibility to the antibacterial activity of serum. Hence we can place a question „Which 
feature of bacteria determines their behaviour in the serum as an environment to live?“. 
Because OMPs are also surface virulence factors and have a significant role in 
pathobiology of Gram-negative bacteria and bacterial adaptation to environmental 
conditions, many authors have directed their investigations through the analysis of 
Salmonella OMP patterns using various molecular methods to investigate these antigens 
(see below). OMPs are of special interest to researchers as they can modify the 
susceptibility of bacteria to the bactericidal activity of serum (Alberti et al., 1993; Kustos et 
al., 2007).  
The above-mentioned authors (Bugla-Ploskonska et al., 2011, 2010a, 2010b, 2009b, 2009c; 
Futoma et al. 2005) and Sarowska and co-workers (2010) described the results of Salmonella 
susceptibility to human and bovine serum. Bactericidal activity of serum was determined 
as described previously (Doroszkiewicz, 1997). In short, adequately prepared bacteria 
were incubated with diluted serum (12.5%, 25% or 30%, 50% and 75% in physiological 
saline) in a water bath at 37°C. The number of colony-forming units per milliliter 
(CFU/ml) at time 0 was taken as 100%. Strains with survival rates greater than 100% in 
serum after 180 min of incubation were considered resistant, and those with survival rates 
less than 100% were considered susceptible to the bactericidal action of the serum. The 
results of Salmonella O48 susceptibility to serum are presented in Table 2. The last column 
of Table 2 lists the molecular weights of OMPs, which are characteristic only for a given 
serovar and are characteristic for only resistant or sensitive strains. 
The studies were carried out on seventeen Salmonella strains, which contain sialic acids in 
the O-specific side chains of LPSs (O48 somatic antigen group):  
S. enterica subsp. arizonae PCM 2543, S. enterica subsp. arizonae PCM 2544, S. enterica subsp. 
salamae sv. Ngozi PCM 2514, S. bongori sv. Balboa PCM 2552, S. enterica subsp. salamae sv. 
Hammonia PCM 2535, S. enterica subsp. salamae sv. Hagenbeck PCM 2534, S. enterica 
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subsp. enterica sv. Dahlem PCM 2512, S. enterica subsp. enterica sv. Djakarta PCM 2513, S. 
enterica subsp. enterica sv. Toucra PCM 2515, S. enterica subsp. enterica sv. Hisingen PCM 
2536, S. enterica subsp. salamae sv. Sakaraha PCM 2538, S. sp. PCM 2548, S. enterica subsp. 
diarizonae PCM 2511, S. bongori sv. Bongori PCM 2547, S. enterica subsp. salamae sv. 
Erlangen PCM 2533, S. enterica subsp. houtenae sv. Marina PCM 2546, S. enterica subsp. 
enterica sv. Sydney PCM 2551. The strains were obtained from the Polish Collection of 
Microorganisms (PCM), Ludwik Hirszfeld Institute of Immunology and Experimental 
Therapy, Polish Academy of Sciences, Wroclaw, Poland. The rest of the tested strains, 
shown in Table 2) had been isolated from fecal samples from children with gastroenteritis 
at the Lower Silesian Pediatric Center in Wroclaw during 2009-2010, and they were S. 
enterica subsp. enterica sv. Typhimurium (O4), S. enterica subsp. enterica sv. Enteritidis 
(O9), S. enterica subsp. enterica sv. Hadar (O8). Susceptibility of these serovars to 50% 
normal human serum was established by Sarowska et al. (2010).  
Eleven strains of Salmonella O48 were sensitive to the bactericidal effect of human, bovine or 
cord serum, whereas six Salmonella O48 strains, and serotypes of somatic antigen groups, O4, 
O9, and O8 demonstrated higher resistance to the bactericidal activity of the serum. In other 
experiments, aimed at analyzing the mechanism of serum complement activation, serovars, 
which were sensitive to the bactericidal action of serum, were used. Bugla-Ploskonska et al. 
(2010a, 2010b, 2009b) examined serum in which AP or CP/LP pathways of C were inhibited. 
Authors established the following mechanisms of complement activation by Salmonella O48. 
- CP - only the classical/lectin pathways were important in the bactericidal mechanism of 
complement activation, 
- AP - only the alternative pathway was important in the bactericidal mechanism of 
complement activation, 
- CP/AP - independent activation of the classical/lectin pathways and enhancing the 
alternative pathway in the bactericidal mechanism of complement activation, 
- CL + AP - parralel activation of the classical/lectin and enhancing the alternative 
pathway in the antibacterial activity of complement system.  
It is interesting and new information that the strains possessing the same somatic antigen 
group O48 present diverse susceptibility to serum and different patterns of C activation. 
Sarowska and co-workers (2010) examined that Salmonella ESBL+ transconjugants belonging 
to three serovars: Enteritidis, Typhimurium, and Hadar were more sensitive to NHS than 
before conjugation process. It seems that the acquisition of new plasmids from Klebsiella 
pneumoniae (donor) might have unfavourable consequences for these bacteria and increased 
their susceptibility to serum activity. A probable explanation of this could be the remodeling 
of the envelope of the bacterial cells, e.g. OM composition.  
It was shown, that the complex bacterial stress response may be conducted with the 
releasing of the outer membrane vesicles. McBroom and Kuehn (2007) demonstrated that 
the quantity of vesicle release correlates with the level of toxic misfolded protein 
accumulation in the cell envelope. Accumulation of material occurs when cells are 
exposured to damaging stressors such as temperature, nutrient availability, toxic agents. 
This process can act to selectively eliminate unwanted material. Further work is required to 
identify how envelope stress translates into bacterial resistance in serum. Native vesicles 
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contain OM and periplasmic material, and they are released from the bacterial surface 
without loss of membrane integrity. More surprisingly, vesicles from some species contain 
DNA (Nikaido, 2003). These vesicles, however, have not been well characterized in most 
studies. For example, the reported protein composition of vesicles from P. aeruginosa is 
strikingly different from that of the OM (Kadurugamuwa and Beveridge, 1995). Vesicles 
were shown to be enriched in monomeric OM proteins, OmpA, OmpX, and OmpW, but 
contain less of the trimeric porins OmpF and OmpC (Horstman and Kuehn, 2000). Hellman 
et al. (2000) showed that bacterial OMPs are released into serum in complexes that also 
contain LPS. Release of 18-kDa OMP from E. coli J5 into serum was greater for bacteria in 
early logarithmic than in late logarithmic growth and was increased by antibiotics in vitro 
and in vivo. These data raise the question as to whether released OMPs, such as the 18-kDa 
OMP, could play a role in the pathogenesis of Gram-negative sepsis.  
Strain no Sera 
Concentration of serum 
OMPs 
(kDa)1 
12.5 % 25% or 30% 50% 75% 
SENSITIVE STRAINS 
S. arizonae 
PCM 2543 
NHS 
NBS 
NT2 
sensitive 
sensitive 
sensitive 
sensitive 
sensitive
sensitive
60, 48, 453 
S. arizonae 
PCM 2544 
NHS 
NBS 
NT 
sensitive 
sensitive 
sensitive 
sensitive 
sensitive
sensitive
60, 31, 24, 
123 
S. Ngozi PCM 
2514 
NHS 
NBS 
NT 
sensitive 
sensitive 
sensitive 
sensitive 
sensitive
sensitive
58, 45, 423 
S. Balboa 
PCM 2552 
NHS 
NBS 
NT 
sensitive 
sensitive 
NT 
sensitive 
sensitive
sensitive
49, 46, 393 
S. Hammonia 
PCM 2535 
NHS 
NBS 
NT 
sensitive 
sensitive 
NT 
sensitive 
sensitive
sensitive
573 
S. Hagenbeck 
PCM 2534 
NHS 
NBS 
NT 
sensitive 
sensitive 
NT 
sensitive 
sensitive
sensitive
47, 313 
S. Dahlem 
PCM 2512 
NHS 
NCS 
NBS 
NT 
sensitive 
NT 
NT 
sensitive 
sensitive 
sensitive 
sensitive 
sensitive 
sensitive
sensitive
sensitive
50 
S. Djakarta 
PCM 2513 
NHS 
NCS 
NBS 
NT 
sensitive 
NT 
NT 
sensitive 
sensitive 
sensitive 
sensitive 
sensitive 
sensitive
sensitive
sensitive
56 
S. Toucra 
PCM 2515 
NHS 
NCS 
NBS 
NT 
resistant 
NT 
NT 
sensitive 
sensitive 
sensitive 
sensitive 
sensitive 
sensitive
sensitive
sensitive
none4 
S. Hisingen 
PCM 2536 
NHS 
NCS 
NBS 
NT 
resistant 
NT 
NT 
resistant 
sensitive 
sensitive 
sensitive 
sensitive 
sensitive
sensitive
sensitive
56 
S. Sakaraha 
PCM 2538 
NHS 
NCS 
NBS 
NT 
resistant 
NT 
NT 
resistant 
resistant 
sensitive 
sensitive 
sensitive 
sensitive
sensitive
sensitive
none4 
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RESISTANT STRAINS5  
S. sp. PCM 
2548 
NHS 
NCS 
NBS 
NT 
NT 
NT 
NT 
NT 
sensitive 
resistant 
NT 
resistant 
resistant
NT 
resistant
93, 62, 30, 
25, 173 
S. diarizonae 
PCM 2511 
NHS 
NCS 
NBS 
NT 
resistant 
NT 
NT 
resistant 
sensitive 
sensitive 
resistant 
sensitive 
sensitive
resistant
sensitive
194, 84, 66, 
8 
S. Bongori 
PCM 2547 
NHS 
NCS 
NBS 
sensitive 
resistant 
NT 
sensitive 
resistant 
sensitive 
sensitive 
resistant 
sensitive 
sensitive
resistant
sensitive
183, 99 
S. Erlangen 
PCM 2533 
NHS 
NCS 
NBS 
sensitive 
resistant 
NT 
sensitive 
resistant 
resistant 
sensitive 
resistant 
sensitive 
sensitive
resistant
sensitive
69, 54, 8 
S. Marina 
PCM 2546 
NHS 
NCS 
NBS 
NT 
resistant 
NT 
NT 
resistant 
resistant 
NT 
resistant 
resistant 
resistant
resistant
resistant
41 
S. Sydney 
PCM 2551 
NHS 
NCS 
NBS 
resistant 
resistant 
NT 
sensitive 
resistant 
resistant 
sensitive 
resistant 
resistant 
sensitive
resistant
resistant
74 
S. 
Typhimurium  
NHS 
NCS 
NBS 
NT NT 
resistant 
NT 
NT 
NT 
NT 
NT 
82, 66, 65, 
51, 41, 27, 
25, 17 
S. Enteritidis  
NHS 
NCS 
NBS 
NT NT 
resistant 
NT 
NT 
NT 
NT 
NT 
79, 66, 65, 
53, 41, 29, 
27, 17 
S. Hadar  
NHS 
NCS 
NBS 
NT NT 
resistant 
NT 
NT 
NT 
NT 
NT 
82, 66, 65, 
51, 41, 27, 
25, 17 
References: Bugla-Ploskonska et al. (2011, 2010a, 2010b, 2009b, 2009c); Futoma et al. (2005); Sarowska et 
al. (2010) 
NHS – normal human serum; NCS – normal cord serum; NBS – normal bovine serum 
1 OMPs characteristic for only serum- sensitive strains (not present in serum-resistant strains) or for 
only serum-resistant strains (not present in serum-sensitive strains) 
2 NT – not tested 
3 data presented only in this paper 
4 there are any individual OMPs in this strain when compare to others 
5 strains were regarded as resistant when their survival was above 100% in the highest concentrations of 
serum 
Table 2. The susceptibility of Salmonella strains to NHS, NCS, and NBS put together with 
OMPs 
3.1 The role of sialylated lipopolysaccharide 
Bacteria have evolved mechanisms for evading recognition by the immune system. 
Sialylation of LPS or LOS mediates serum resistance of N. gonorrhoeae (Ram et al., 1998). 
Sialic acids are important constituents of glycoconjugates in animal tissues, which regulate 
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innate immunity. Covering bacterial surfaces with sialylated oligosaccharides mimic those 
of the host (molecular mimicry). Incorporation of NeuAc into the surface components of the 
cell envelope of some pathogenic bacteria inhibits the direct activation of the alternative 
complement pathway (Rautemaa and Meri, 1999). Activation of AP is regulated by an 
interaction between C3b and factor H. It is known that NeuAc can enhance the binding of 
factor H to C3b on the cell surface, which blocks the amplification of the AP of C activation. 
fH is a critical regulator of the C system, and acts a a cofactor for factor I-mediated cleavage 
of C3b. fH also inactivates AP convertase by dissociating Bb from the C3bBb complex 
(Pangburn et al., 1977). Interestingly, the positive effect of LPS sialylation on fH binding 
requires the presence of gonococcal porin PorB, suggesting that sialylation may cause a 
conformational change in the LPS that unmasks novel sites in PorB (Severi et al., 2007). 
Smooth strains of S. Typhimurium (nonsialylated) were usually resistant to the action of 
serum, whereas strains of the Ra chemotype by sera of some piglets were killed (Dlabac, 
1968). It was shown that the LPS O-antigen (O-Ag) plays an important role in resistance to 
complement-mediated serum killing in several Gram-negative bacteria (Bengoechea et al., 
2004, Grossman et al., 1987, Joiner, 1988). It was shown that LPS O-antigen and the outer 
core of Y. enterocolitica do not contribute directly to complement resistance. Instead, the 
major Y. enterocolitica serum resistance determinants include OMPs such as YadA and Ail 
(Kirjavainen et al., 2008). 
It was reported that the amount of O-Ag and its chain length distribution are important 
factors in protecting bacteria from serum complement. Bravo et al. (2008) demonstrated that 
increased amounts of length distribution produced by S. Typhi grown to stationary phase 
confered higher levels of bacterial resistance to human serum. They suggest that O-Ag is 
more important for survival of S. Typhi in serum than the Vi antigen, and that non-
typhoidal serovars are more resistant than serovar Typhi to human serum. 
3.2 The role of OMPs 
The sensitivity of bacteria to the bactericidal activity of serum depends on the structure and 
organization of their outer membrane. About 50% of OM consists of proteins, so their role in 
the pathogenicity of Gram-negative bacteria cannot be dismissed (Koebnik et al., 2000). The 
resistance of bacteria to serum’s lytic activity may be one of the virulence factors essential in 
the development of sepsis. Changes in OMPs‘ expression can result in Gram-negative bacteria 
developing resistance to the bactericidal activity of serum (Bugla and Doroszkiewicz, 2006; 
Weiser and Gotschlich, 1991; White et al., 2005; Attia et al., 2005; Nishio et al., 2005). Studies 
have shown that porins from several bacteria stimulate cells to produce and secrete cytokines 
(Galdiero et al., 1993). Whole bacterial cells, which express on their surface LPS and porins 
both use CD14 when interact with leukocydes. Galdiero and others (2001) showed that CD14 
and CD11a/18 are involved in cytokine responses to LPS, but only CD11a/18 is involved in 
those of porins. Their previous studies (Galdiero et al., 1990) showed that S. Typhimurium 
porins inhibit phagocytosis by activating the adenylate cyclase system. 
Some OMPs amplify the sensitivity of bacteria (Zollinger et al., 1987, Merino et al., 1998, 
Alberti et al., 1993) to serum. Binding of OmpK36 of the serum sensitive strain K. pneumoniae to 
C1q leads to activation of the complement classical pathway and the subsequent deposition of 
C components C3b and C5b-9 on the porin (Alberti et al., 1996). Y. enterocolitica serum 
resistance is dependent of the presence of proteins YadA and Ail, which bind C4b-binding 
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protein, an inhibitor of both the classical and lectin pathways of C (Kirjavainen et al., 2008). 
Another example of the serum resistance phenotype of bacteria is Actinobacillus 
actinomycetemcomitans expressing surface protein Omp100, which traps factor H, an inhibitor 
for C3 (Asakawa et al., 2003). Futoma-Koloch et al. (2006) investigated the serial passage of 
Proteus mirabilis O18 in 90% bovine serum what contributed to over-expression of some classes 
of OMPs. It was also found a large heterogeneity of the OMPs’ profile among Salmonella spp. 
after their passage in serum (Skwara et al., 2011). Studies of Kroll and co-authors (1983) have 
shown that treating E. coli cells with sera also generates changes in their OMPs composition.  
Many years ago, some authors (Joiner et al., 1982; Taylor, 1983) suggested that the nature of 
bacterial resistance to the action of sera is quite complex. Galdiero et al. (1984) showed that 
the C system could be activated by porins isolated from S. Typhimurium. Chaffer et al. 
(1999) showed that E. coli O2 isolates that possess 35 kDa OmpA are higly resistant to the 
bactericidal effect of serum. Others (Cirillo et al., 1996) pointed out that Rck (17-19 kDa) 
protein in S. Typhimurium is associated with high–level serum resistance. This OMP 
probably inhibits lysis of the bacterial cell that occurs with the MAC complex. S. 
Choleraesuis‘ resistance to serum may be enhanced by the presence of the outer membrane 
protein PagC (17 kDa) (Nishio et al., 2005). Rck is a member of a family of OMP including 
PagC of S. Typhimurium (Gunn et al., 1995) and Ail of Y. enterocolitica (Miller et al., 1990). 
Site-directed mutagenesis and “domain-swapping” experiments done with Rck show that 
loop 3 is required for serum resistance and invasion in E. coli (Cirillo et al., 1996).  
Bugla-Ploskonska and co-workers (2011) confirmed that certain OMPs are characteristic of the 
serum-resistant and serum-sensitive phenotypes of Salmonella O48 to the bactericidal action of 
cord serum (see Table 2.). But the SDS-PAGE (sodium dodecyl sulphate-polyacrylamide gel 
electrophoresis) analysis of the OMPs isolated from: S. Hisingen PCM 2536, S. Dahlem PCM 
2512, S. Djakarta PCM 2513, S. Toucra PCM 2515, S. Sakaraha PCM 2538, S. diarizonae PCM 
2511, S. Bongori PCM 2547, S. Erlangen PCM 2533, S. Marina PCM 2546, and S. Sydney PCM 
2551, showed no correlation between numbers of colored stripes within the same path and the 
susceptibility of the tested strains to cord serum. The strain, which was most sensitive to the 
lytic activity of cord serum S. Dahlem PCM 2515 had 32 OMPs with distinct molecular 
weights, while serum-resistant S. Marina PCM 2546 had only 20 OMPs.  
When comparing the results of Bugla-Ploskonska et al. (2011) (data not shown in Fig. 1.), 
Sarowska et al. (2010) (Fig. 1.A) and Futoma-Koloch et al. (data published in this paper) (Fig. 
1.B) one may note different electrophoretic band patterns for OMPs of tested strains of 
Salmonella. The patterns of OMPs (Fig. 1.) are similar to those reported in the literature, and 
allow the identification of the major proteins, including the 36- to 41-kDa proteins known as 
porins (Kamio and Nikaido, 1977). These proteins, which were common in S. Typhimurium, 
S. Enteritidis, and S. Hadar strains, are 66-, 65-, 41-, 27-, and 17-kDa. These results are 
similar to that obtained for S. Typhi by Ortiz et al. (1989), which had 17-, 28-, and 36- to 41-
kDa proteins. While studying the composition of OM of S. Typhimurium, Smit and Nikaido 
(1978) observed that these bacteria contain three porins of 34-, 35-, and 36-kDa. 
As show in Fig 1., the tested strains share the same OMP peptide band located at 35 kDa, the 
region containing the OmpA. This protein has been shown to contribute to the increased 
resistance of E. coli to the bactericidal effect of serum by classical pathway activation. All the 
serum-resistant strains S. sp. PCM 2548 (Fig. 1.B, line 2), S. diarizonae PCM 2511, S. Bongori 
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PCM 2547, S. Erlangen PCM 2533, S. Marina PCM 2546, S. Sydney PCM 2551 (Bugla-
Ploskonska et al., 2011), S. Enteritidis, S. Typhimurium, and S. Hadar (Sarowska et al., 2010) 
(Fig. 1.A, lines 3, 5, 7) possess additional proteins, not present in the strains, which were 
susceptible to serum. This suggests, some OMPs are characteristic of sensitive strains (group 
1), as well as associated with resistant strains (group 2): 
 Group 1, consisting of eleven serovars sensitive to the bactericidal action of serum (see 
Table 2.). The OMPs characteristic of this group of bacteria were not detected in the 
outer membranes of the strains resistant to the bactericidal action of serum: 60-, 58-, 57-, 
56-, 50-, 49-, 48-, 47-, 46-, 45-, 42-, 39-, 31-, 24-, 12-kDa; 
 Group 2, consisting of nine serovars resistant to the bactericidal action of serum (see 
Table 2.) The OMPs characteristic of this group of bacteria were not detected in the 
outer membranes of the strains sensitive to the bactericidal action of serum: 194-, 183-, 
99-, 93-, 84-, 82-, 79-, 74-, 69-, 66-, 65-, 62-, 54-, 53-, 51-, 41-, 30-, 29-, 27-, 25-, 17-, 8-kDa. 
 
(A)     (B) 
Fig. 1. The SDS-PAGE OMPs isolated with Zwittergent 3-141 
The results presented by Sarowska et al. (2010) show that the ESBL conjugative plasmid 
donor strain K. pneumoniae, and recipient strains (S. Enteritidis, S. Typhimurium and S. 
Hadar) were resistant to the bactericidal action of NHS, whereas the three Salmonella 
transconjugants identified as ESBL producers (S. Enteritidis ESBL+, S. Typhimurium ESBL+, 
and S. Hadar ESBL+) demonstrated sensitivity to serum. SDS-PAGE analysis of the OMPs of 
Salmonella transconjugants revealed that the parental strains (Fig. 1.A, lines: 3-S. Enteritidis; 
5-S. Typhimurium, 7-S. Hadar) and transconjugants (Fig. 1.A, lines 4, 6, 8) exhibited slightly 
                                                 
1 Lane 1 (A, B): Molecular Weight Standards (Sigma); (A) 2: K. pneumoniae; 3: S. Enteritidis; 4: S. 
Enteritidis ESBL+; 5: S. Typhimurium; 6: S. Typhimurium ESBL+; Lane 7: S. Hadar; Lane 8: S. Hadar 
ESBL+ (Sarowska et al., 2010); with permission of Editor-In-Chief of Advances in Clinical and Experimental 
Medicine (B) 2: S. sp. PCM 2548; 3: S. Balboa PCM 2552; 4: S. arizonae PCM 2543; 5: S. arizonae PCM 2544; 
6: S. Ngozi PCM 2514; 7: S. Hammonia PCM 2535; 8: S. Hagenbeck PCM 2534 (data shown only in this 
paper). 
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different outer-membrane banding patterns. These changes included the presence or 
absence of particular OMPs. New OMPs (absent before conjugation) with molecular masses 
of 25-kDa and 44-kDa were observed in S. Enteritidis ESBL+ isolate, and 43-kDa in S. 
Typhimurium ESBL+ strain. The acquisition of ESBL plasmids also resulted in the loss of 
some OMPs in the transconjugants compared with the parental strains. In the case of the S. 
Enteritidis ESBL+ isolate, no bands for the 15-, 22-, 53-, 58- and 78-kDa protens were noted. 
For the remaining transconjugants no bands were observed for the 16-, 38-, 44-, 55-, and 82-
kDa proteins (S. Typhimurium ESBL+) and 27-, 65- and 66-kDa (S. Hadar ESBL+).. 
In our study, all the Salmonella strains tested, regardless of their susceptibility to serum, 
possessed the 35-kDa peptide band (Fig. 1.). Note that Rck of S. Typhimurium and S. 
Enteritidis, binds fH, which is accociated with resistance to the alternative pathway of 
complement (Ho et al., 2010), allowing to analyse OMPs patterns on this basis. In the studies 
of Salmonella O48 strains, it was shown that alternative pathway was important in the 
bactericidal mechanisms of C activation, in spite of the fact that some strains had 17- or 19-
kDa proteins, as can be seen in Fig. 1. It seems that any identified agent masks the inhibitory 
properties of 17-19-kDa proteins in Salmonella O48 against the AP pathway.  
Bugla-Ploskonska et al. (2009a, 2011), Futoma-Koloch et al. (2009), and Sarowska et al. (2010) 
used a method of isolating OMPs from bacteria during exponential growth using the 
Zwittergent Z 3-14 detergent (Calbiochem-Behring), primarily used for enrichment of 
proteins from cell lysates. Sulfobetaine 3-14 has a strongly basic quaternary ammonium ion 
and acidic sulfonate with equivalent strength and its zwitterionic character is maintained 
over a wide range of pH. This method was adapted for Salmonella strains using methods 
developed for isolating of OMPs of Branhamella catarrhalis (presently named Moraxella 
catarrhalis) (Murphy and Bartos, 1989, Faden et al., 1992), and Haemophilus influenzae 
(Murphy and Bartos, 1988). There were two modifications introduced into Murphy and 
Bartos’s original method. The first one was that the bacteria were cultured overnight at 37C 
for 18 h within liquid Brain Heart Infusion medium (not on solidified medium, similar as in 
bactericidal assay (YP broth)), secondly, OMPs in a buffer Z, were kept overnight at 4C, 
before they were centrifuged at 8700 rpm at 4C for 10 min. It’s important to emphasize that 
culturing bacteria in liquid or solidified medium may influence the molecular pattern of the 
surface antigens. Harvesting bacteria from plates provides large numbers of cells without the 
need for centrifugation. In this manner, the cells are relatively free from components of the 
growth medium, which could interfere with subsequent procedures. Zwitterionic detergents 
like non-ionic detergents do not possess a net charge; they lack conductivity and 
electrophoretic mobility, and do not bind to ion exchange resins. Like ionic detergents, they 
are also suited for breaking protein-protein interactions (Srirama, 2001).  
Hundreds of articles have been published with the words “Salmonella OMP” or “Salmonella 
porin“. Of note is the review by Nikaido (2003), who has been working in that field during 30 
years of his scientific carrier. He exhaustively described the molecular basis of bacterial OM 
permeability, taking into concideration i.a. protein channels, and LPS. Since the OMPs are 
surface-exposed antigens, they provide attractive targets for the development of vaccines, thus 
various techniques have been developed for their characterization. OMPs isolated with 
Zwittergent Z 3-14 can be also separated with two-dimensional electrophoresis (2-DE). 
Preliminary studies by Futoma-Koloch et al. (2009), Bugla-Ploskonska et al. (2009a) have 
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reported that using the zwitterionic detergent Zwittergent Z 3-14 is suitable to isolate OMPs 
from S. arizonae, S. Dahlem, and other Gram-negative rods such as E. coli O56. Samples of 
these peptides may then be separated by 2-DE in a capillary tube system (Futoma-Koloch et 
al., 2009) (Fig. 2.). It was also shown that the use of the same detergent to isolate OMPs from E. 
coli O56 enables their separation by 2-DE using pH 3-10 immobilized pH gradient IPG strips 
(Bugla-Ploskonska et al., 2009a). Detection of hydrophobic OMPs in 2-D gels is associated with 
certain limitations (Fountoulakis, 2005). The poor solubility of hydrophobic OMP accounts for 
their absence from the 2D gel map, but the addition of zwitterionic detergents can improve 
protein solubilization (Shaw and Riederer, 2006). 
 
Fig. 2. 2-DE profile of OMPs isolated with Zwittergent Z 3-14: S. arizonae PCM 2543 
(Futoma-Koloch et al. 2009)2 
2-DE was carried out with the Mini-PROTEAN 3 System (Bio-Rad) and Protean IEF cell 
and Mini-Protean Tetra Cell (BioRad) respectively (Fig. 2.). Spots of OMPs of S. arizonae 
PCM 2543 were visualized by silver staining. Some modifications were introduced into to 
the original method described by O’Farrell in 1975 (O’Farrell, 1975) in order to improve the 
resolution of OMPs isolated with Zwittergent 3-14. It was necessary to reduce the molar 
concentration of urea and replace Bio-Lyte 5/7 ampholyte with ddH2O in three reagents: the 
first-dimension sample buffer, the first-dimension sample overlay buffer, and the first-
dimension gel monomer solution. Tricine was used instead of glycine in the electrophoresis 
buffer (second dimension). The tube gels were pre-electrophoresed (electrode preparation) 
by running at 200 V for 10 min, 300 V for 15 min, and 400 V for 15 min (power supply 
adaptor - Apelex PS 900S TX) then appropriate prepared samples were loaded on the top 
surfaces of the gels in capillary tubes and separated by IEF on pH 3.0-10.0 at 300 V for 16 h, 
400 V for 2 h, and 800 V for 1 h (Apelex PS 900S TX). Three tube gels per sample were run. 
After the IEF (isoelectring focusing) run was completed, gels were electrophoresed 
according to Laemmli (1970) for 2 h (20 mA/gel) and stained with a Silver Stain PlusTM kit 
(Bio-Rad). Fig. 2. contains a total of 35 spots. The major proteins were found in the acidic 
                                                 
2 With permission of Editor-In-Chief of Polish Journal of Microbiology 
 
Salmonella – Distribution, Adaptation, Control Measures and Molecular Technologies 
 
278 
regions of the gels. This procedure was described in details in paper autorship Futoma-
Koloch et al. (2009). 
The next issue for consideration concerns various methods developed for isolation, separation 
and identification of OMPs. The power of 2-DE in the OMPs analysis was demonstrated by 
Hamid and Jain (2008), who confirmed that OMPs provide promising targets for the 
development of a candidate vaccine against typhoid. 2-DE methodology in conjunction with 
the Western Blot has a potential for the rapid development of specific, safe, and highly 
efficacious vaccines against salmonellosis in human and livestock. Non-detergent 
sulphobetaines were also used by Blisnick and co-workers (1998) to enhance the recovery of 
membrane proteins and active proteases from erythrocytes infected by Plasmodium falciparum, 
a parasite. Protein extracts of parasites obtained with NDSB195 (non-detergent sulfobetaine) 
were separated by IEF, as well as by SDS-PAGE. Proteins were then identified with western 
blotting using specific antibodies. S. Typhimurium served as a model for isolating OMPs by 
the method of Foulaki et al. (1989). From the urea extract a 55-kDa protein was isolated by ion-
exchange chromatography and gel filtration free of LPS. All steps in the isolation of this 
protein were carried out without detergents. 
Huang et al. (2004) presented a newly developed method combining sucrose density 
centrifugation and aqueous two-phase partitioning for the isolation of pure OM from 
Synechocystis sp. The purity of the membrane fractions was verified by immunoblot analysis 
using Ab against specific membrane marker proteins. They have examined the protein 
composition by 2-DE followed by matrix-assisted laser desorption/ionization time–of-flight 
(MALDI-TOF) analysis. Using a combination of two nonionic detergents (CHAPS and ASB-
14), proteins were solubilized and resolved within a range of pH 4.0-7.0. The studies of Ortiz 
et al. (1989) were undertaken to assess the ability of the OMPs of S. Typhi to induce a 
humoral immune response in human with typhoid fever. OMPs in this case were isolated 
with the nonionic detergent, Triton X-100. Proteins were contaminated with approximately 
4% LPS. SDS-PAGE patterns showed protein bands with molecular size ranges from 17 to 70 
kDa. The major group of proteins corresponded to the OmpA. Isibasi et al. (1988) isolated 
OMPs from S. Typhi also with Triton X-100, as described by Schnaitman (1971). Seleim and 
others (2002) performed preparation of the Salmonella OMPs with 2% sarkosyl in 10 mM 
HEPES buffer. Chooneea et al. (2010) attempted to characterize the surface proteome of S. 
Typhimurium using lipid-based protein immobilization technology in the form of LPITM 
FlowCell. No detergents were required and no sample clean up was needed prior to 
downstream analysis. The proteins were then characterized by liquid chromatography – 
tandem mass spectrometry (LC-MS/MS). In these studies 54 OMPs were identified.  
Proteomic analysis of the E. coli OM performed by Molloy and co-workers (2000) included 
isolation of cell membranes by carbonate extraction according to the method of Fujiki and co-
workers (1982). Bolla et al. (2000) developed a method for purification of the major outer 
membrane protein (MOMP) of Campylobacter, involving outer-membrane preparation 
followed by specific detergent extraction and chromatography. In that study, to identify 
poorly expressed porin proteins, they analysed a large amount of outer membrane detergent 
extract by ion-exchange chromatography. This method allowed them to identify and 
characterize a novel porin protein Omp50 of C. jejuni. Extraction of the porin from the 
membrane was carried out in six steps. Two extractions with 0.1% sodium lauryl sarcosinate in 
Tris buffer to solubilize the inner membrane were followed by four successive extractions with 
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n-octyl- polyoxyethylene (octyl-POE; Bachem AG-Switzerland) in 20 mM NaPi (pH 7.6), 
leading to the specific recovery of the outer membrane porin associated with octyl-POE 
micelles. In turn, OMPs of Brucella spp. were extracted with Triton X-114 (Tibor et al., 1999), 
and confirmed to be lipoproteins.  
The preparations of OMPs in the soluble fraction in buffer Z (in a method with Zwittergent 
Z-14) were assayed for the enzymatic activity of succinic dehydrogenase, a marker for the 
cytoplasmic membranes, according to Rockwood et al. (1987). To make certain that the 
extracts of proteins were free of membrane fraction contaminations, Futoma-Koloch and 
others (data shown only in this paper) employed transmission electron microscopy (TEM) 
for imaging OMPs isolated from S. arizonae PCM 2544.  
For electron microscopy investigation:  
a. The isolated material was negatively contrasted with 2 % uranyl acetate in a 
conventional procedure (Fig. 3.A); 
b. For thin-sections isolated material was fixed in 1% osmium tetroxide, dehydrated in 
graded ethanol and embedded in Epon 812. Ultrathinsections were cut with a Reychert 
Ultracut E ultramicrotome and stained with lead citrate (Fig. 3.B). 
The specimens were examined in Tesla BS 540 electron microscope. The proteins appeared 
bright against the dark background. Scale markers correspond to 500 nm. Note, that 
membrane contarrdinants are not present. If they were, they would be visible as white 
linear trails of phospholipid bilayers. Proteins or peptides released from the membranes 
tend to aggregate to assume globular or filamentous clusters of the diameter from 40 nm 
to about 200 nm. 
  
Fig. 3. Transmission electron micrographs of isolated OMPs released with Zwittergent 3-14 
from S. arizonae PCM 2544, bar=500nm, 25 000x 
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4. Salmonella’s OMPs as potential vaccines 
Another aspect of studying OMPs of Gram-negative bacteria is the potential for finding 
molecular candidates for vaccines. Vaccination is an effective tool for the prevention of 
Salmonella infections (Mastroeni et al., 2011). The currently available vaccines against 
salmonellosis can be divided into three major classes: whole-cell killed vaccines, subunit 
vaccines, and live attenuated vaccines. Subunit vaccines such as the ones based on the Vi 
polysaccharides are safe, immunogenic, and are currently licenced for human use. Other 
subunit vaccines such as those based on detoxified LPS, cell extracts, porins, O-
polysaccharides, and O-conjugates have been tested in experimental models (Mastroeni 
and Menager, 2003). Recognition and neutralization of OMPs by the immune system is of 
great importance. When porins are used as immunogens they can ablate bacteremia and 
provide equivalent protection against salmonellosis. Available vaccines containing either 
acetone or heat-killed S. Typhi are of limited value, because they confer short-lived 
protection and they produce unacceptable side effects, due mainly to the presence of 
endotoxin, which prevents their use in children. At the moment there are also several 
vaccines prepared from Vi antigen.  
The trimeric porins show stability to temperature and denaturants, and are also resistant to 
proteolysis. These properties make them good candidates for industrial applications 
towards the development of oral vaccines (Galdiero et al., 1990). Data delivered by Salazar-
Gonzales et al. (2004) showed that S. Typhi porins-based candidate vaccine is safe and 
immunogenic and healthy. They observed that side effects after vaccination were mild and 
transient. Ortiz et al. (1989) established that sera from patients with typhiod fever contained 
M antibodies, which reacted with a protein of 28-kDa. Singh and others (1995) were 
interested in OmpC and OmpD porins from S. Typhimurium because of their potential role 
in diagnostic assays, in antibiotic resistance, and as immunogens for vaccination. 
In animal models, it was shown that mouse monoclonal antibodies were raised against 
recombinant S. Typhi 36-kDa porin monomer (Kissel et al., 1994). Hamid and Jain (Hamid 
and Jain, 2008) investigated OMPs of S. Typhimurium as potential vaccine candidates for 
conferring protection against typhoid. They showed that OMP with an apparent molecular 
mass of 49-kDa were highly immunogenic, evoke humoral and cell-mediated immune 
responses and confer 100% protection to immunized rats. Seleim and co-workers (2002) 
compared patterns of OMPs bands in SDS-electrophoretic analysis, and found common 
protein bands in the range from 20-45 kDa in four serovars of Salmonella (Typhimurium, 
Dublin, Enteritidis, and Anatum) collected from calves’ fecal samples. The OMPs of serovars 
Dublin and Enteritidis reacted similar in the Western Blot method with the antisera collected 
from infected calves. Two protein bands were characteristic, one at, 14.4- and the other at 24-
kDa. The authors conclude that Salmonella OMPs can be employed as effective vaccine 
candidates. Vaccination could confer active immunity and reduce the expenses associated 
with treating Salmonella-infected calves. Studies of Maripandi and Al-Salamah (2010) were 
conducted on S. Enteritidis isolates from chicken meat samples for OMPs analysis. The 
immunoblotting results showed that 14.4- and 24-kDa proteins were good chicken 
immunogens. The authors conclude that these proteins can be used for vaccine preparation 
in the future. Outer membrane proteins 82- and 76-kDa are potentially involved in the 
attachment of S. Enteritidis to the intestinal mucosa. They could be used as vaccines to block 
or reduce S. Enteritidis colonization in chickens (Fadl et al., 2002). Ochoa-Reparaz et al. 
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(2004) state that the immunogenicity of S. Enteritidis porins in infected birds may serve as 
components of an effective subcellular vaccine for poultry salmonellosis.  
VonSpecht and co-workers (1996) tested the ability of the recombinant OprI of P. aeruginosa to 
serve as a protective vaccine against this Gram-negative pathogen. Oral immunization of mice 
with recombinat OprI expressing S. Dublin, induced s-IgA antibodies in the gut mucosa 
against OprI. Recombinant Lactobacillus casei may also express SipC and OmpC antigens for 
vaccination against infections caused by S. Enteritidis (Kajikawa and Shizunobu, 2007). 
Attenuated Salmonella species expressing heterologous antigens are promising candidates 
for the development of mucosal vaccines. This strategy is based on the ability of Salmonella 
bacteria to persist in the antigen-presenting cells (APC) during its migration to the lyphatic 
organs of the mucosal immune system. Oral live vaccines based on recombinant Salmonella 
strains were successfully developed to induce a specific immune response against human 
immunodeficiecy virus, Helicobacter pylori, Clostridium difficile, and human papilloma virus 
in mice and humans (Heinz et al., 2004).  
The ability of OMPs to induce a protective immunity against infection caused by diverse 
Gram-negative bacteria, such as H. influenzae type b (Granoff and Cates, 1986), N. 
meningitidis group B (Wang, 1984), P. aeruginosa (Gilleland et al., 1984), S. Typhimurium 
(Kuusi et al., 1979) and Borrelia bronchiseptica (Montaraz et al., 1985), has been demonstrated 
previously. Witkowska and others (2006) showed that a 38-kDa OMP present in most 
Enterobacteriaceae species is a protein that generates immunological response in human 
organisms and is a good candidate for creating a vaccine against such species as E. coli, 
Shigella flexneri, K. pneumoniae, and Proteus vulgaris. 
5. Conclusions 
The phenomenon of serum resistance of bacteria has a multifactorial basis. Alteration of 
the Gram-negative bacterial envelope, including altered protein and LPS composition, 
may be considered as before general mechanism for survival within the host. Further 
studies are required to better understand all the molecular mechanisms of microbial 
surface remodeling and the process of recognizing of the outer membrane vesicles from 
the bacteria. The role of OMPs, LPSs, and LOSs in determining serum-sensitivity or 
serum-resistance in Salmonella is not entirely clear. It is important to determine which 
OMPs from Salmonella are immunogenic in animals as well as in humans, in order to 
improve subunit vaccines against salmonellosis. 
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